Aims: The efficacy of paclitaxel-eluting stents (PES) in patients with ST-segment elevation acute myocardial infarction (STEMI) has not been demonstrated yet. The aim of the present study w
1. Division of Interventional Cardiology, University Hospital La Paz, Madrid, Spain; 2. Cardiology Department, Cochin Hospital, Paris, France; 3. Department of Interventional Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands; 4. Universit
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
acute myocardial infarctioncoronary stentpaclitaxel
Read next articleA pooled safety analysis of data comparing paclitaxel-eluting stents with bare-metal stents